文献速递炎症性肠病消化道肿瘤与早癌

克罗恩病患者肛管高危人乳头瘤病毒感染高发

High Prevalence of Anal Canal High-Risk Human Papillomavirus Infection in Patients With Crohn's Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-03-15

研究分析了2012年4月1日至2015年4月30日在法国某消化科接受结肠镜检查的469例连续患者,检测肛管组织HPV DNA,发现34%感染HPV、18%感染高危HPV,克罗恩病患者高危HPV感染比例显著高于非克罗恩病患者。

要点

  • 结肠镜检查患者中34%检出肛管HPV DNA,18%检出高危HPV。
  • 克罗恩病患者高危HPV感染率30.0%,显著高于非患者的18.1%。
  • 女性、性传播疾病史、性伴侣数、吸烟和免疫抑制治疗是高危HPV独立危险因素。

核心结论

  • 在消化科接受结肠镜检查的患者中,约三分之一存在肛管HPV感染,近20%存在高危HPV感染。
  • 克罗恩病患者高危HPV感染比例显著高于非克罗恩病患者。

研究设计与样本

  • 研究分析了2012年4月1日至2015年4月30日法国某消化科469例连续接受结肠镜检查患者的肛管组织样本,中位年龄54岁,52%为女性,其中112例接受免疫抑制治疗,101例患有炎症性肠病(70例为克罗恩病)。
  • 采用INNO-LiPA方法检测HPV并分型,收集所有受试者的医疗和人口学数据,通过双变量和多变量分析评估任何HPV、高危HPV和HPV16感染的危险因素。

主要发现

  • 肛管组织HPV DNA检出率为34%,高危HPV检出率为18%。
  • HPV16是最常见的基因型(检出率7%),其次为HPV51、HPV52和HPV39。
  • 女性高危HPV检出率23.1%,显著高于男性的12.8%(P = .0035)。
  • 克罗恩病患者高危HPV和HPV16检出率为30.0%,显著高于非克罗恩病患者的18.1%(P = .005)。
  • 多变量分析显示,女性、性传播疾病史、终生及过去一年性伴侣数、当前吸烟和免疫抑制治疗是肛管高危HPV感染的独立危险因素。

关键数值与推荐

  • 高危HPV在女性中的检出率为23.1%,在男性中为12.8%(P = .0035)。
  • 高危HPV和HPV16在克罗恩病患者中的检出率为30.0%,在非克罗恩病患者中为18.1%(P = .005)。

临床怎么用

  • 作者认为,提高对肛管组织HPV感染的认识可帮助医生识别高危人群,并促进疫苗接种预防和适当筛查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The increasing incidence of anal canal carcinomas requires better knowledge on anal human papillomavirus (HPV) infection. We aimed to assess anal canal HPV infection prevalence and risk factors among patients seen at a gastroenterology department in France. METHODS: We analyzed anal tissue samples collected from 469 consecutive patients (median age 54 years, 52% women), including 112 who received immunosuppressant therapies and 101 with inflammatory bowel disease (70 with Crohn's disease), who underwent colonoscopy examinations from April 1, 2012 to April 30, 2015. HPV was detected and genotyped using the INNO-LiPA assay, and we collected medical and demographic data from all subjects. Risk factors for any HPV, high-risk HPV (HR-HPV) and HPV16 infection were assessed by bivariate and multivariate analysis. The primary outcomes association of HR-HPV or HPV16 with medical and demographic features. RESULTS: We detected HPV DNA in anal tissues from 34% of the subjects and HR-HPV in 18%. HPV16 was the most prevalent genotype (detected in 7%), followed by HPV51, HPV52, and HPV39. HR-HPV was detected in a significantly higher proportion of samples from women (23.1%) than men (12.8%) (P = .0035); HR-HPV and HPV16 were detected in a significantly higher proportion of patients with Crohn's disease (30.0%) than without (18.1%) (P = .005). Female sex, history of sexually transmitted disease, lifetime and past year-number of sexual partners, active smoking, and immunosuppressive therapies were independent risk factors for anal HR-HPV infection in multivariate analysis. CONCLUSION: One third of patients who underwent colonoscopy at a gastroenterology department were found to have anal canal HPV infection. We detected HR-HPV infection in almost 20% of patients and in a significantly higher proportion of patients with Crohn's disease than without. Increasing our knowledge of HPV infection of anal tissues could help physicians identify populations at risk and promote prophylaxis with vaccination and adequate screening.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Vuitton L, Jacquin E, Parmentier AL, et al. High Prevalence of Anal Canal High-Risk Human Papillomavirus Infection in Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2018. PMID: 29551740. doi:10.1016/j.cgh.2018.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。